Laura Ellis and Michael Lampert on Learning from Healthcare Corporate Integrity Agreements [Podcast]




Compliance Perspectives show

Summary: <a href="http://complianceandethics.org/wp-content/uploads/2018/08/podcast-graphic-1024x1024.png"></a><br> <a href="http://complianceandethics.org/wp-content/uploads/2015/02/turteltaub-adam-200x200-150x1501.jpg"></a><br> By Adam Turteltaub<br> adam.turteltaub@corporatecompliance.org<br> No one wants to work under a Corporate Integrity Agreement (CIA), but there are lots of good lessons that can be learned from them.<br> <a href="mailto:Ellis,%20Laura%20E%20(OIG/OCIG)%20%3cLaura.Ellis@oig.hhs.gov%3e?subject=Your%20HCCA%20Podcast">Laura Ellis</a>, Senior Counsel in the Office of Special Counsel to the Inspector General at HHS, and <a href="mailto:Michael.Lampert@ropesgray.com?subject=Your%20HCCA%20Podcast">Michael Lampert</a>, a partner in the Boston office of Ropes &amp; Gray will be addressing CIAs in their session at the 2019 <a href="http://www.compliance-institute.org">Compliance Institute</a> in Boston.<br> In this podcast they reveal some of the insights they will be sharing at the conference.  They focus on three elements now found in all CIAs:<br> <br> * Board members are required to pass a resolution finding that their compliance program is effective and in compliance with the corporate integrity agreement provisions.<br> * Senior managers must sign an annual certification that they have been trained on compliance, are aware of the compliance program, have operated their department in a compliant manner, and are not aware of any improper behavior.<br> * The company undergo an annual compliance risk assessment.<br> <br> These elements are designed to ensure that compliance cascades through the organization and that the compliance program remains dynamic and aligned with key risks for healthcare providers.<br> Listen in to learn more about the OIG’s office’s approach, and then join them at the 2019 Compliance Institute.<br>